XML 20 R7.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Cash flows from operating activities:    
Net loss $ (36,935) $ (5,805)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock-based compensation 2,583 234
Change in fair value of redeemable convertible preferred stock tranche liability 11,718 0
Amortization of premiums and accretion of discounts 83 0
Foreign currency gain from remeasurement (245) 59
Changes in operating assets and liabilities:    
Prepaid expenses and other assets 11,103 (2,235)
Long-term assets 2,633 (1,361)
Accounts payable 1,494 82
Accrued liabilities 1,760 611
Accounts payable and accrued liabilities, related party (176) (59)
Net cash used in operating activities (28,188) (8,474)
Net Cash Provided by (Used in) Investing Activities [Abstract]    
Purchase of marketable securities (106,919) 0
Net cash used in investing activities (106,919) 0
Cash flows from financing activities    
Proceeds from issuance of common stock sold in initial public offering, net issuance costs 83,144 0
Proceeds from issuance of redeemable convertible preferred stock, net of issuance costs 93,939 0
Proceeds from the exercise of stock options 111 0
Net cash provided by financing activities 177,194 0
Effect of exchange rate changes on cash and cash equivalents 245 (59)
Net change in cash and cash equivalents 42,332 (8,533)
Cash and cash equivalents at beginning of period 20,487 21,223
Cash and cash equivalents at end of period 62,819 12,690
Supplemental disclosure of cash flow information:    
Conversion of redeemable convertible preferred stock to common stock 152,759 0
Redeemable convertible preferred stock accretion $ 0 $ 1,352